Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833

NCT02437227 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators